Journal article
Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report
Therapeutic Advances in Rare Disease, Vol.4, pp.1-7
01/2023
DOI: 10.1177/26330040221145945
PMCID: PMC10032445
PMID: 37181073
Abstract
Mucopolysaccharidoses (MPS) are a group of inherited lysosomal storage disorders caused by deficient levels and/or activity of glycosaminoglycan (GAG)-degradative enzymes. MPS are characterized by accumulation of the mucopolysaccharides heparan sulfate, dermatan sulfate, keratan sulfate, or chondroitin sulfate in tissues. We report the case of a 38-year-old woman with a history of joint restriction and retinitis pigmentosa who developed bivalvular heart failure requiring surgery. It was not until pathological examination of surgically excised valvular tissue that a diagnosis of MPS I was made. Her musculoskeletal and ophthalmologic symptoms, when placed in the context of MPS I, painted the diagnostic picture of a genetic syndrome that was overlooked until a diagnosis was made in late middle age. Plain Language Summary A 38-year-old woman with heart failure had heart valve surgery. Examining her cardiac valve tissue under the microscope suggested a metabolic disorder called mucopolysaccharidosis type I (MPS I). MPS I is due to defective breakdown of sugar molecules (called glycosaminoglycans or GAGs for short) in the body which then can accumulate, causing dysfunction. Our patient had short stature, a curved spine, stiff joints, and a degenerative eye disease called retinitis pigmentosa, all of which were due to her undiagnosed MPS I. Most patients with MPS I are discovered on newborn screening when they are babies, or at very young ages due to severe symptoms related to the disease. Our patient had a form of MPS I that was less severe, and the first symptom she received medical care for was her eye symptoms. A diagnosis of MPS I made in middle adulthood is unusual for MPS I, and so is an important learning case for providers as there were clues hidden in her medical history that suggested a genetic or inherited syndrome. Our genetics specialists were able to make a definitive diagnosis of MPS I and begin treatment with enzyme replacement therapy, as well as provide information for the patient about her risk of passing this disease on to children.
Details
- Title: Subtitle
- Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report
- Creators
- Faizal Z. Asumda - Augusta University HealthJessica A. Kraker - Department of Ophthalmology, Mayo Clinic, Rochester, MN, USASarah C. Thomas - Department of Pathology, Mayo Clinic, Rochester, MN, USAJoseph Maleszewski - Department of Pathology, Mayo Clinic, Rochester, MN, USAEdwin M. Stone - University of IowaBrendan C. Lanpher - Mayo ClinicLisa A. Schimmenti - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Therapeutic Advances in Rare Disease, Vol.4, pp.1-7
- DOI
- 10.1177/26330040221145945
- PMID
- 37181073
- PMCID
- PMC10032445
- NLM abbreviation
- Ther Adv Rare Dis
- ISSN
- 2633-0040
- eISSN
- 2633-0040
- Language
- English
- Date published
- 01/2023
- Academic Unit
- The University of Iowa Institute for Vision Research; Iowa Neuroscience Institute; John and Marcia Carver Nonprofit Genetic Testing Laboratory; Family and Community Medicine; Ophthalmology and Visual Sciences
- Record Identifier
- 9984360034102771
Metrics
7 Record Views